Boston Scientific Corporation Stock
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.84 USD | -3.77% |
|
-7.10% | +5.06% |
| Dec. 08 | Why the Fed's Next Move Matters More Than Markets Admit |  |
| Dec. 08 | Analyst recommendations: 3M Company, Exxon Mobil, Mastercard, Netflix, Tesla… | |
| Capitalization | 139B 120B 112B 104B 193B 12,541B 210B 1,310B 507B 5,921B 522B 511B 21,694B | P/E ratio 2025 * |
45.4x | P/E ratio 2026 * | 36.6x |
|---|---|---|---|---|---|
| Enterprise value | 148B 127B 120B 111B 205B 13,339B 224B 1,393B 540B 6,298B 555B 543B 23,073B | EV / Sales 2025 * |
7.37x | EV / Sales 2026 * | 6.46x |
| Free-Float |
84.69% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | -3.77% | ||
| 1 week | -7.10% | ||
| Current month | -7.62% | ||
| 1 month | -6.18% | ||
| 3 months | -13.22% | ||
| 6 months | -8.08% | ||
| Current year | +5.06% |
| 1 week | 92.72 |  | 99.34 |
| 1 month | 92.72 | | 105.65 |
| Current year | 85.98 | | 109.5 |
| 1 year | 85.98 | | 109.5 |
| 3 years | 44.35 | | 109.5 |
| 5 years | 33.42 | | 109.5 |
| 10 years | 15.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 60 | 2011-10-31 |
Jonathan Monson
DFI | Director of Finance/CFO | 51 | 2025-06-29 |
John Sorenson
COO | Chief Operating Officer | 57 | 2022-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
John Sununu
BRD | Director/Board Member | 60 | 2009-03-31 |
Michael Mahoney
CHM | Chairman | 60 | 2016-05-02 |
Edward Ludwig
BRD | Director/Board Member | 73 | 2014-02-28 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.75% | 26 M€ | +11.55% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.77% | -7.10% | +4.19% | +102.59% | 139B | |
| -0.80% | -2.89% | +7.34% | +0.05% | 213B | |
| -1.47% | -0.08% | +2.99% | +108.40% | 201B | |
| -0.78% | +0.15% | -2.45% | -17.42% | 159B | |
| +0.21% | +1.95% | -16.92% | -12.97% | 56.15B | |
| -2.17% | -1.11% | +17.88% | +16.34% | 48.93B | |
| -2.10% | -5.10% | +1.32% | -8.86% | 40.32B | |
| -2.77% | +4.86% | +2.28% | - | 37.85B | |
| -2.54% | +0.67% | +3.57% | +12.38% | 36.44B | |
| -1.16% | -0.78% | -23.88% | -36.29% | 34.22B | |
| Average | -1.43% | -0.90% | -0.37% | +18.25% | 96.6B | |
| Weighted average by Cap. | -0.90% | -1.60% | +1.80% | +34.72% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 20.08B 17.28B 16.22B 15.08B 27.8B 1,810B 30.33B 189B 73.2B 855B 75.35B 73.73B 3,131B | 22.37B 19.26B 18.08B 16.81B 30.98B 2,017B 33.79B 211B 81.58B 952B 83.96B 82.17B 3,489B |
| Net income | 3.02B 2.6B 2.44B 2.27B 4.18B 272B 4.56B 28.44B 11.01B 129B 11.33B 11.09B 471B | 3.76B 3.24B 3.04B 2.82B 5.2B 339B 5.68B 35.39B 13.71B 160B 14.11B 13.8B 586B |
| Net Debt | 8.85B 7.62B 7.15B 6.65B 12.25B 798B 13.36B 83.3B 32.26B 377B 33.2B 32.49B 1,380B | 5.45B 4.69B 4.41B 4.1B 7.55B 492B 8.24B 51.35B 19.88B 232B 20.47B 20.03B 850B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-08 | 93.84 $ | -3.77% | 14,721,272 |
| 25-12-05 | 97.52 $ | -0.20% | 8,145,496 |
| 25-12-04 | 97.72 $ | -0.86% | 9,407,689 |
| 25-12-03 | 98.57 $ | -0.45% | 9,868,971 |
| 25-12-02 | 99.02 $ | -1.97% | 7,977,843 |
Delayed Quote Nyse, December 08, 2025 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
